Fount Bio
PrivateLast Round
Series A
Feb 28, 2022
Company Overview
Fount Bio operates in Healthcare & Life Sciences and is based in Somerville, Massachusetts. Its latest recorded funding round was a Series A round in February 2022.
Fount Bio is a life sciences company that develops innovative, glycopolymer-based products for medical aesthetics and consumer beauty applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fount Bio Comparables
Compare Fount Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eirion Therapeutics | 78% | |
| Innoture | 67% | |
| Teoxane Laboratories | 66% |
For institutional investors. Book with your work email.
Fount Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Fount Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 32% month-over-month.
- Apr 17, 2026
Monthly visitors grew 6400% MoM, from 18 to 1.2K.
For institutional investors. Book with your work email.
Fount Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fount Bio's valuation, stock price, and market status.
Is Fount Bio a public or private company?
Fount Bio is a private company.
What is the current stock price of Fount Bio?
Fount Bio is a private company, so its shares have no public market price. Caplight tracks Fount Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fount Bio worth (valuation)?
Valuation information for Fount Bio is not publicly available.
Can I buy Fount Bio stock?
Fount Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fount Bio's last funding round?
Fount Bio's most recent funding round was Series A on February 28, 2022.
Who are the main investors in Fount Bio?
Key investors in Fount Bio include Morningside Ventures.
Will Fount Bio IPO soon?
No public IPO plans have been announced for Fount Bio.
How can I track Fount Bio secondary market activity?
Caplight tracks bids, offers, and trades in Fount Bio's shares on secondary markets.